These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9114962)

  • 1. Study of the duration and distribution of equine influenza virus subtype 2 (H3N8) antigens in experimentally infected ponies in vivo.
    Sutton GA; Viel L; Carman PS; Boag BL
    Can J Vet Res; 1997 Apr; 61(2):113-20. PubMed ID: 9114962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis and clinical signs of equine herpesvirus-1 in experimentally infected ponies in vivo.
    Sutton GA; Viel L; Carman PS; Boag BL
    Can J Vet Res; 1998 Jan; 62(1):49-55. PubMed ID: 9442940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid diagnosis of equine influenza.
    Anestad G; Maagaard O
    Vet Rec; 1990 Jun; 126(22):550-1. PubMed ID: 2164275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
    Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
    Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of infectivity of a canine lineage H3N8 influenza A virus in ponies and in primary equine respiratory epithelial cells.
    Quintana AM; Hussey SB; Burr EC; Pecoraro HL; Annis KM; Rao S; Landolt GA
    Am J Vet Res; 2011 Aug; 72(8):1071-8. PubMed ID: 21801065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of influenza A/equine/H3N8 virus isolate variation on the measurement of equine antibody responses.
    Bogdan JR; Morley PS; Townsend HG; Haines DM
    Can J Vet Res; 1993 Apr; 57(2):126-30. PubMed ID: 8387870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM; Yates PJ; Newton JR; Park A; Henley W; Wood JL; Davis-Poynter N; Mumford JA
    Vaccine; 2004 Sep; 22(29-30):4101-9. PubMed ID: 15364463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses.
    Wattrang E; Jessett DM; Yates P; Fuxler L; Hannant D
    Viral Immunol; 2003; 16(1):57-67. PubMed ID: 12725689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of A/eq-1 virus isolated during the equine influenza epidemic in India.
    Singh G
    Acta Virol; 1994 Feb; 38(1):25-6. PubMed ID: 8067310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of influenza nucleoprotein antigen in nasal secretions from horses infected with A/equine influenza (H3N8) viruses.
    Cook RF; Sinclair R; Mumford JA
    J Virol Methods; 1988 May; 20(1):1-12. PubMed ID: 2840448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.
    Crouch CF; Daly J; Henley W; Hannant D; Wilkins J; Francis MJ
    Vet Immunol Immunopathol; 2005 Dec; 108(3-4):345-55. PubMed ID: 16098611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring and detection of acute viral respiratory tract disease in horses.
    Mumford EL; Traub-Dargatz JL; Salman MD; Collins JK; Getzy DM; Carman J
    J Am Vet Med Assoc; 1998 Aug; 213(3):385-90. PubMed ID: 9702229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time RT-PCR for detection of equine influenza and evaluation using samples from horses infected with A/equine/Sydney/2007 (H3N8).
    Foord AJ; Selleck P; Colling A; Klippel J; Middleton D; Heine HG
    Vet Microbiol; 2009 May; 137(1-2):1-9. PubMed ID: 19153018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).
    Mumford J; Wood JM; Scott AM; Folkers C; Schild GC
    J Hyg (Lond); 1983 Jun; 90(3):385-95. PubMed ID: 6306098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.